Analytical Method Development and Validation for the Estimation of Zolmitriptan by RP HPLC Method

International Journal of Trend in Scientific Research and Development (IJTSRD)
Volume 3 Issue 5, August 2019 Available Online: www.ijtsrd.com e-ISSN: 2456 – 6470
@ IJTSRD | Unique Paper ID – IJTSRD26474 | Volume – 3 | Issue – 5 | July - August 2019 Page 804
Analytical Method Development and Validation for
the Estimation of Zolmitriptan by RP HPLC Method
Mr. Rahul M. Sagde, Mr. Pawan N. Karwa, Mr. Vivek M. Thorat, Sanjay S. Jadhav
Ph.D Scholar, Gurukrupa Institute of Pharmacy, Majalgaon, Maharashtra, India
How to cite this paper: Mr. Rahul M.
Sagde | Mr. Pawan N. Karwa | Mr. Vivek M.
Thorat | Sanjay S. Jadhav "Analytical
Method Development and Validation for
the Estimation of Zolmitriptan by RP
HPLC Method"
Published in
International
Journal of Trend in
Scientific Research
and Development
(ijtsrd), ISSN: 2456-
6470, Volume-3 |
Issue-5, August 2019, pp.804-810,
https://doi.org/10.31142/ijtsrd26474
Copyright © 2019 by author(s) and
International Journalof Trendin Scientific
Research and Development Journal. This
is an Open Access article distributed
under the terms of
the Creative
CommonsAttribution
License (CC BY 4.0)
(http://creativecommons.org/licenses/by
/4.0)
ABSTRACT
In this work the authors have proposed a simple, specific, economic and
accurate reverse phase liquid chromatographic method for the estimation of
Zolmitriptan as an active pharmaceutical ingredient and in pharmaceutical
formulation. The main objective of the current research paperisto Todevelop
simple, precise and accurate RP-HPLCmethod for Zolmitriptan alsotovalidate
the developed method as per ICH guideline Q2R1 and to explore the
applicability of the method in finished product formulation for estimation of
Zolmitriptan during its lifecycle. The objective was achieved by optimized
condition with Phonemenex C18 column (150mm×4.6mm), 5μm. And mobile
phase Phosphate buffer (pH 3.5) 85: Methanol 15. The separation was done
with a flow rate of 0.9ml/min, detection with 224nm. The retentionwasfound
to be 3.57 minute. LOD and LOQ were found to be 2.45 and 7.42 respectively.
So in order to obtain the correct results various validations methods are
performed to get the results. The results obtained from those validation
methods are plotted in the form of the charts as well as the different curves.
KEYWORDS: Zolmitriptan; HPLC; Analytical method; validation
1. INTRODUCTION
Zolmitriptan is a potent antimigraine drug. It is white in color. The structure is
depicted in the figure1. the chemical formula is C16H21N3O2. The molecular
weight is 287.35. It is used in the treatment of the acute treatment of adult
migraine with or without auras. It works by binding to the 5-HT1B and 5-HT1D
receptors leading to cranial blood vessel constriction. It gets metabolized with
the help of indole acetic acid, N -oxide, and N-desmethyl metabolites.
However, N-desmethyl is the only active metabolite. The
chromatography is used in the Validation for the estimation
of the Zolmitriptan by RP-HPLC Method.
High-PerformanceLiquid Chromatography(HPLC) isusedto
provide information on the composition of drug related
samples. The information obtained may be qualitative,
indicating what compounds are present in the sample or
quantitative, providing the actual amounts of compounds in
the sample. HPLC is used routinelyduringdrugmanufacture.
Chromatography is a technique that separates components
in a blend due to the inconsistent time takenforeach analyte
to travel through the stationary phase when carriedthrough
it by the mobile phase. The stationary phase is fixed in place
either in column (a hollow tube made up out of a suitable
material, eg. Glass) or on a planner surface and the mobile
phase move about or through the stationary phase carrying
with it the sample of interest. In exercise the stationary gas
chromatography and supercriticalfluid chromatography the
stationary phase is fixed in place in a column in liquid
chromatography the stationary phase may be fixed in place
either in a column or on a phase can be a solid, a liquid
adsorbed on a solid or an organic species (eg. A c18 alkyl
chain) bonded to a solid surface.1
1.1. Classification2–5
IJTSRD26474

International Journal of Trend in Scientific Research and Development (IJTSRD) @ www.ijtsrd.com eISSN: 2456-6470
1.2. Types of chromatography:
Normal phase chromatography 6
Reverse-phase chromatography 7
High-performance liquid chromatography (HPLC) is
basically a highly Developed form of column liquid
chromatography. As in normal solvent is allowed to drip
through a column under gravity, it is instead forced through
under high pressures of up to 400 atmospheres. That makes
it much it much faster. All chromatographicseparations,also
the HPLC works under the same basic principle which states
that separation of a sample into itsconstituentpartsbecause
of the difference in the relative affinities for the different
molecules for the mobile phase and the stationary phase
used in the separation. The components of the HPLC are
shown in fig 2 8
2. Experimental work
2.1. Reagent and Chemical:
Drug sample was obtained from Cadila Healthcare
Ahmedabad, HPLC grade Methanol, Triethylamine,
Orthophosphoric acid, Potassium dihydrogen phosphate,
Anhydrous disodium hydrogen phosphate was obtained
from Merk.
2.2. Chromatographic Condition:
The basic Chromatographic Condition that was strictly
followed during the research was as follows. The column
selected should be Phenomenex C18 with the size as
(150mm×4.6mm), 5μm id. The mobile phase used should be
of phosphate buffer with pH 3.5, in ratio with the methanol
as 85:15. The detection wavelength wasusedfor224nm. The
flow time was about 0.9ml per min. The temperature should
be Ambient throughout the work. The size of thesample was
about 10 μl and the time of the working should be 6 min
only.
2.3. Preparation of Phosphate Buffer, 0.025 M
Standard:
Dissolved 3.40g of potassium dihydrogen phosphate and
3.55g of anhydrous disodium hydrogen phosphate, both
previously completely dried at 110º to 130º for 2 hours, in
water to produce about 1000 ml sol.9
2.4. Preparation of standard stock solution of ZMT:
Accurately weighed 10mg of ZMT and transferred to100 ml
volumetric flask containing few ml of mobile phase (buffer
85: Methanol 15 at pH 3.5). The volume was made up to the
mark using mobile phase slowly and with mild shaking to
make the resultant solution of 100μg/ml. This solution was
ultrasonicated for 20 min in two cycles each of 10 min. Also,
it was the filter through a 0.45μ membrane filter.
2.5. Preparation of working solution of ZMT
1.0ml of this solution was withdrawn and diluted to 10ml
with mobile phase (buffer 85: Methanol 15 at pH 3.5) to
make the resultant solution of 10μg/ml. This solution was
ultrasonicated for 30 min in three cycles each of 10 min.
Also, it was then filtered through a 0.45μ membrane syringe
filter. This solution was then used for further analysis.
3. Result and Discussion
3.1. Material Characterization
3.1.1. Melting point:
Here Melting point of Zolmitriptan (ZMT) was determined
using digital melting point apparatus (Labatronics) by
capillary method and found to be 137º C. The reference
melting point of ZMT was 136 -141°C. Finally, the
experimental melting point was found in conformity with
standard melting point (136-141º C).
3.1.2. determination of absorption maxima:
The absorption maximum of ZMT was determined in the
mobile phase of phosphate bufferpH3.5 andmethanolinthe
ratio of 85:15. The 10μg/ml solution was selected for this
experiment and the same wasprepared asper theprocedure
used earlier. The UV spectrum obtained was as shown in
Figure 3. the maximum absorbancewasobtained at224 nm.
The same was used for the setting of UV detector in HPLCfor
detection of ZMT. It is shown in table 1.
The study was performed by six repeated measurements of
the 10μg/ml solution of ZMT in the given chromatographic
conditions as given earlier. Each chromatogram obtained
was recorded and integrated to determine peak area,
retention time, tailing factor and number of theoretical
plates. The representative chromatogram for the study was
as shown in Figure 4. The peak areaandretentiontime were
further evaluated by applying statistical parameters like
standard deviation and percent relative standard deviation.
The results obtained were as depicted in Table 2. From the
results obtained the %RSD obtained for peak area and
retention time was found within acceptance criteria as per
ICH guideline Q2R1. Therefore, it was concluded that the
method passed for the test of system suitability testing.
3.2 Method validation:
3.2.1 Linearity and Range:
Linearity is defined as the mathematical relationship which
can be can be graphically represented as a straight line,
between the two quantities that are directly proportional to
each other. From stock solution aliquots of 1.0, 2.0, 3.0, 4.0,
5.0 and 6.0ml were pipetted out and diluted up to 10ml to
obtain the resultant solutions of 10, 20, 30, 40, 50 and
60μg/ml respectively. Each of this solution was injected to
the given chromatographic conditions and chromatograms
were recorded. The mean peak area was determined by
integration of chromatograms. The calibration curve was
constructed between concentrations of standard solutions
versus peak area. Results were recorded for the equation of
the line, correlation coefficient and intercept.
Y = mX + c
Where, Y = Peak area; m = slope; X = measured
concentration; c = intercept
The linearity of the method was assessed by injecting
standard solutions in the range of 10 to 60μg/mlintriplicate
to the given chromatographic conditions and mean peak
area was determined in each case. The resulting mean peak
areas for six standard solutions obtained were asdepicted in
Table 3. It was then plotted against the concentration to
obtain a calibration curve. Thecalibrationcurveobtained for
ZMT was as shown in Figure5 below. From the calibration
curve obtained an equation of line was determined and was
found to be
Y = 30753x – 30217
The correlation coefficient was determined and found to be
0.9987. As the value for correlation coefficientwasverynear
to linearity, it was concluded thatthedeveloped method was
found to linear for the standard solutions of ZMT in the
range of 10-60μg/ml.

3.2.2 Precision:
Precision is the measure of how close the data values are to
each other for a number of measurements under the same
set of experimental conditions. Theprecisionofan analytical
method is usually expressed as the standard deviation or
relative standard deviation (coefficient of variation) of a
series of measurement.
The precision of the method was established by defining
three quality control standards across the given range of 10
to 60μg/ml. Precision was studied by two different means
viz. by assessing repeatability and intermediate precision.
Repeatability was assessed in triplicate in a day after an
interval of three hrs each. However, intermediate precision
was performed on three different days. From the calibration
range, three QC standards were defined viz. 15, 35 and
55μg/ml as LQC, MQC and NQC respectively. The solutions
for QC standards were prepared by diluting the main stock
standard solution of 1.5, 3.5 and 5.5ml up to 10ml. These
three solutions were injected to given chromatographic
conditions in triplicate and the mean peak area was then
determined. Results were recorded to calculate mean, SD,
%RSD. The results obtained for a precision experimentwere
as shown in Table 4. As shown in Table 4 the mean peak
area obtained in the precision experiment to establish
repeatability and intermediate precision was further
subjected to statistical analysis to determine standard
deviation and percent relative standard deviation. The
results obtained for %RSD were less than 2% i.e. within
acceptable limits as pet ICH Q2R1 guidelines. Hence, it was
concluded that the present method successfully passed for
the test for precision as per ICH Q2R1 guideline.
3.2.3 Accuracy:
The accuracy of the analytical method is the closeness of the
test result obtained by the method to the true value. %
Accuracy was determined fromtheobservationsof precision
study using the following formula, shown in Eq.1
Limit for % accuracy is NMT 5% RSD.
The results obtained for percent accuracy study were as
illustrated in Table 5. The results obtained for percent
accuracy were in the range of 81.76 to 97.99 % w/w. Out of
the results obtained the percent accuracy was failed for the
concentration of ZMT at 35μg/ml. However, the agreement
of results showed percent RSD within acceptance criteria.
3.2.4 Robustness:
The robustness of an analytical procedure is defined as the
measure of its capacity to remain unaffected by any of the
small, but it is deliberate variations in method parameters
and provides an identification mark of its reliability after its
normal usage. Robustness of the method was established by
a certain variation in method parameters.In thismethod, the
parameters like organic concentration of the mobile phase
and flow rate were varied as per Table 6. The 10μg/ml
concentration was selected forthisexperimentandthesame
was kept constant during all variations made in the method
parameters. The selected concentration was injected three
times at each level of change and chromatogram recorded.
From the chromatograms obtained mean peak area was
determined. It was the used for calculation mean measured
concentration at each level of change and finally for
determination of percent assay. The results were evaluated
for compliance with the pharmacopoeial standards and
displayed in table 7, 8
The chromatograms were recorded for each deliberate
variation in method parameter and correspondingpeak area
was determined. Hence it was concluded that the method
was proved to be robust for deliberate variation in method
parameters.
3.2.5 %Recovery:
Percent recovery is the determination of percent purity of
given drug analyte in the finished product. Percent recovery
experiments were carried out using spike method (standard
addition method) at three different levels (80%, 100% and
120%) Known amounts of standard solutions containing
analyte were added to pre-quantifiedsamplesolutionsto get
80, 100 and 120% levels. These samples were analyzed by
injecting the sample solution for a given chromatographic
condition in triplicates. 10mg of ZMT (API) was weighed
accurately and transferred to 100ml volumetric flask
containing some amount of mobile phase and volume was
made up to the mark using mobile phase to obtain a
concentration of 100μg/ml. The resulting solution was
filtered through 0.45μ membrane filter and sonicated for
three cycles each of 10 min. From the stock solution 1.0ml
was withdrawn using micro-pipette in triplicate and kept in
three different 10 ml volumetric flasks, cleaned previously
and diluted up to 10ml by using mobile phase to obtain
resultant solution of 10μg/ml. These solutionswereinjected
for given chromatographic system in triplicate and mean
peak area was determined and was and it was subtracted
from the area of corresponding standardsolution(10μg/ml)
to attain actual peak area for sample solution The results
obtained were in compliance with thecompendialstandards
for Zolmitriptan as per USP. Therefore, eventually, it was
concluded that the presented developed and validated
method can be successfully used for the scheduled
quantitative determination of ZMT in the capsule dosage
form. Figure 6 indicates theChromatogramof ZMTobtained
for % recovery experiment, Eq.2
3.2.6 LOD and LOQ:
The detection limit is a characteristic of the limit test. It is
defined as the lowest amount of analyte in a sample that can
be detected, but not quantitated, under the particular
experimental conditions. The quantitation limit is one of the
characteristicpropertyof quantitative assaysforcompounds
with the low level in sample matrices, such as impurities in
bulk drug substances and degradation products in finished
pharmaceuticals. Limit of detection (LOD) and Limit of
quantitation (LOQ) were determined from the following
formulae, Shown in Eq.3. The LOD and LOQ should be
expressed in μg/ml for ZMT. The results acquired for LOD
and LOQ were as illustrated in Table 10 From the results
obtained, it can be stated that the amount of ZMT as low as
2.45 and 7.42 can be successfully detected and quantified
respectively using the proposed method. Therefore, it was
concluded that the method was sensitive enough for
estimation of ZMT as drug substance.
STEYX =
STEYX as per MS excel = STEYX (known_y's,known_x's)
Where STEYX = Standard error of Y and X-axis.

4. Conclusion
The present study was aimed to develop a sensitive, precise
and accurate RP-HPLC method for the analysis of
Zolmitriptan in bulk and pharmaceutical dosage forms.
Different Mixtures of phosphate buffer (25mM, pH 3.5) and
methanol combinations were tested as a mobile phase on a
C18 stationary phase. A mixture of the buffer: Methanol
(pH 3.5) in a proportion of 85:15v/v was proved to be the
most suitable of all combinations since the chromatographic
peaks were better defined and resolvedand almostfreefrom
tailing. The retention time obtained for Zolmitriptan was
3.57min. System suitability parameters were studied with
within the acceptance criteria as per ICH Q2R1 guideline.
The peak areas of Zolmitriptan were reproducible as
indicated by % RSD within the limit. A good linear
relationship (r2=0.9987) was observed between the
standard concentration of Zolmitriptan and the respective
peak areas. The regression curve was constructed by linear
regression fitting and itsregressionequationwas y= 30753x
– 30217 (Where Y gives peak area and X is the concentration
of the Zolmitriptan). The presented method was validated
for following parameters as per ICH guideline Q2R1 this
validation Hence, it was concluded that the proposed RP-
HPLC method was sensitive and reproducible for the
analysis of Zolmitriptan in pharmaceutical dosage form
(capsules) with short analysis time.
Conflict of Interest: The authors declare that there are no
conflicts of interest.
5. References:
[1] B. Harborne, J. Preparative Chromatographic
Techniques-Applications in Natural Product Isolation:
By K. Hostettmann, M. Hostettmann and A. Marston.
Springer, Berlin, 1986. 139 Pp. DM 98. Phytochemistry
1987, 26 (9), 2653–2653 DOI: 10.1016/s0031-
9422(00)83903-5.
[2] Clark Still, W.; Kahn, M.; Mitra, A. Rapid
Chromatographic Technique for Preparative
Separations with Moderate Resolution Figure 2. Silica
Gel Particle Size6 (#rm): (·) r/w; (O) r/(w/2);1978;Vol.
43.
[3] Martin, A. J. P.; Synge, R. L. M. A New Form of
Chromatogram Employing Two Liquid Phases. 1. A
Theory of Chromatography 2. Application totheMicro-
Determination of the Higher Monoamino-Acids in
Proteins. Trends Biochem. Sci. 1977, 2 (11) DOI:
10.1016/0968-0004(77)90204-3.
[4] Jungbauer, A.; Hahn, R. Chapter 22 Ion-Exchange
Chromatography. In Methodsin Enzymology;2009;Vol.
463, pp 349–371.
[5] Fujita-Yamaguchi, Y.AffinityChromatographyof Native
and Recombinant Proteins from Receptors for Insulin
and IGF-I to Recombinant Single-Chain Antibodies.
Frontiers in Endocrinology. 2015.
[6] Meyer, V. R. Practical High-Performance Liquid
Chromatography 5th; 2010.
[7] L.R.Snyder, J.L.Glajch, J. L. K. “Practical HPLC Method
Development”, 2nd Edition.Chromatographia 1998, 47
(3–4), 767 DOI: 10.1007/BF02466588.
[8] David, B.; Matthew, J.; Marisa, A. Remingtonthescience
and practice of pharmacy, ed 21st Lippincott Williams
and Wilkins Publishers: Philadelphia, 2005; pp. 495,
1505, 1711-1712
[9] Indian Pharmacopoeia 2007, Volume 1, Published by
Ministry of Health, Governmentof India,NewDelhi,pp.
248.
Content of Tables
Sr. No. Wavelength (nm) Absorbance
1. 284 0.196
2. 224 1.268
Table 1 Observation table for UV spectrum showing absorbance values at different wavelengths
Sr. No. Parameter Mean observations SD %RSD Acceptance criteria Inference
1 Peak Area 292112.7 4271.27 1.46 < 2 Pass
2 Retention time 3.57 0.02 0.45 < 0.5 Pass
3 Number of Theoretical plates* 2967 -- -- > 2000 Pass
4 Tailing factor* 1.72 -- -- < 2 Pass
Table2 Results obtained for system suitability testing and their evaluation
Sr. No. Conc. (μg/ml) Observed Peak Area Mean Peak Area*
1 10
294993
294813293992
295454
2 20
568762
578853579259
588539
3 30
873109
875051853027
899017
4 40
1216459
12077871186440
1220462

5 50
1489299
14802001471187
1480114
6 60
1831095
18401891860281
1829191
Table3 Observation table for linearity
Table4 Observation table for Repeatability and Intermediate precision experiment
Sr.
No.
Conc.
(μg/ml)
Observed
Peak Area
Mean Peak
Area*
Mean Measured
Conc. (μg/ml)
%
Accuracy
Inference (Std. for ZMT
USP 90-110% w/w)
1 15
417073.67
421815.78 14.70 97.99 Passed417000.67
431373
2 35
838810.33
849840.00 28.62 81.76 Failed853382.33
857327.3
3 55
1512052.67
1521755.78 50.47 91.76 Passed1510312.00
1542903
Table5 Observations for % Accuracy determination from the data obtained for precision experiment
Method parameters Standard Variation 1 Variation 2
Organic concentration of mobile phase (± 2%) 15 17 13
Flow Rate (± 0.05ml) 0.9 0.95 0.85
Table6 Robustness experiment design
Methanol
Concentration
(%)
Standard
Conc.
(μg/ml)
Observed
Peak Area
Mean
peak
area*
Mean
measured
conc. (μg/ml)
%
Assay
Inference (Compendial
standard 90-110
%w/w)
15 10
294993
294813 10.57 105.69 Passed293993
295454
13 10
296033
297590 10.66 106.59 Passed299311
297426
17 10
299492
300924 10.77 107.68 Passed317948
285332
Table7 Observations of robustness experiment for organic concentration variation
Flow Rate
(ml/min)
Standard
Conc. (μg/ml)
Observed
Peak Area
Mean peak
area*
Mean
measured
conc. (μg/ml)
%
Assay
Inference (Compendial
standard 90-110
%w/w)
0.9 10
294993
294813 10.57 105.69 Passed293993
295454
0.95 10
298492
299366 10.72 107.17 Passed310814
288792
0.85 10
297624
302633 10.82 108.23 Passed321537
288738
Table7 Observations obtained for flow rate variation in the robustness experiment
Conc. (μg/ml)
Intra-day precision Inter-day precision
Mean area ± SD % RSD Inference Mean area ± SD % RSD Inference
15 425682.33 ± 3284.62 0.77 Pass 421815.78 ± 8276.88 1.96 Pass
35 853934.33 ± 11764.98 1.38 Pass 849840.00 ± 9753.51 1.15 Pass
55 1521272.33 ± 9587.04 0.63 Pass 1521755.78 ± 18334.41 1.20 Pass

%
Recovery
Level
Conc. of
standard
spiked (μg/ml)
Conc. of the
sample
(μg/ml)
Mean peak
Area of
sample conc.*
Amount
recovered
(μg/ml)
%
Recovery
Inference
(Standards
90-110%w/w)
80 20 16 477154 16.50 103.70 Pass
100 20 20 631795 21.53 109.84 Pass
120 20 24 729010 24.69 105.62 Pass
Table8 Observations obtained for percent recovery study of ZMT in capsule dosage form
Standard Drug Solution LOD (μg/ml) LOQ (μg/ml)
Zolmitriptan 2.45 7.42
Table10 Calculation of LOD and LOQ for the present method
Figures
Figure1 Zolmitriptan [(4S)-4-({3-[2-(dimethylamino)ethyl]-1H-indol-5-yl}methyl)-1,3-oxazolidin-2-on
Figure2 Components of HPLC instrument
Figure 3 UV spectrum of Zolmitriptan recorded in mobile phase phosphate buffer: methanol in the ratio of 85:15
at pH3

Minutes
0.0 0.2 0.4 0.6 0.8 1.0 1.2 1.4 1.6 1.8 2.0 2.2 2.4 2.6 2.8 3.0 3.2 3.4 3.6 3.8 4.0 4.2 4.4 4.6 4.8 5.0 5.2 5.4 5.6 5.8
mAU
-5
0
5
10
15
20
25
30
-5
0
5
10
15
20
25
30
ZOLMITRIPTAN3.58
UV1000-224nm
Name
Retention Time
Figure4 Chromatogram of ZMT obtained in Chromatographic conditions
Figure5 Calibration curve obtained for Zolmitriptan showing linearity with a correlation coefficient of 0.9987
Figure6 Chromatogram of ZMT obtained for % recovery experiment
Equations:
Equation 1 Accuracy
Equation 2 % Recovery
A. B.
Equation 3 A. LOD B. LOQ

Analytical Method Development and Validation for the Estimation of Zolmitriptan by RP HPLC Method

More Related Content

What's hot (19)

Similar to Analytical Method Development and Validation for the Estimation of Zolmitriptan by RP HPLC Method (20)

More from ijtsrd (20)

Recently uploaded (20)

Analytical Method Development and Validation for the Estimation of Zolmitriptan by RP HPLC Method